Chloroquine in combination with aptamer modified nanocomplexes for tumor vessel normalization and efficient erlotinib/Survivin-shRNA co-delivery to overcome drugresistance in EGFR-mutated NSCLC

Chloroquine in combination with aptamer modified nanocomplexes for tumor vessel normalization and efficient erlotinib/Survivin-shRNA co-delivery to overcome drugresistance in EGFR-mutated NSCLC …………… Lv T, Li Z, Xu L, Zhang Y, Chen H, Gao Y. Acta Biomater. 2018 Jun 27. pii: S1742-7061(18)30380-5. PubMed 00